STAAR Surgical Company (FRA:SR3)

STAAR Surgical Company Statistics

Total Valuation

FRA:SR3 has a market cap or net worth of EUR 1.11 billion. The enterprise value is 976.56 million.

Market Cap	1.11B
Enterprise Value	976.56M

Important Dates

The next estimated earnings date is Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	49.74M
Shares Outstanding	n/a
Shares Change (YoY)	-0.15%
Shares Change (QoQ)	+2.08%
Owned by Insiders (%)	0.57%
Owned by Institutions (%)	71.10%
Float	31.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	56.83
PS Ratio	5.62
PB Ratio	3.66
P/TBV Ratio	3.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.85
EV / Sales	4.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.88

Financial Position

The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.11.

Current Ratio	5.21
Quick Ratio	4.16
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	-0.99
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.65% and return on invested capital (ROIC) is -9.10%.

Return on Equity (ROE)	-24.65%
Return on Assets (ROA)	-7.88%
Return on Invested Capital (ROIC)	-9.10%
Return on Capital Employed (ROCE)	-15.88%
Revenue Per Employee	170,442
Profits Per Employee	-71,230
Employee Count	1,157
Asset Turnover	0.46
Inventory Turnover	1.29

Taxes

In the past 12 months, FRA:SR3 has paid 3.78 million in taxes.

Income Tax	3.78M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.09% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-16.09%
50-Day Moving Average	22.69
200-Day Moving Average	18.78
Relative Strength Index (RSI)	49.55
Average Volume (20 Days)	25

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.91

Income Statement

In the last 12 months, FRA:SR3 had revenue of EUR 197.20 million and -82.41 million in losses. Loss per share was -1.67.

Revenue	197.20M
Gross Profit	145.66M
Operating Income	-53.60M
Pretax Income	-78.63M
Net Income	-82.41M
EBITDA	-46.17M
EBIT	-53.60M
Loss Per Share	-1.67

Balance Sheet

The company has 164.76 million in cash and 33.45 million in debt, giving a net cash position of 131.31 million.

Cash & Cash Equivalents	164.76M
Total Debt	33.45M
Net Cash	131.31M
Net Cash Per Share	n/a
Equity (Book Value)	302.55M
Book Value Per Share	6.13
Working Capital	221.99M

Cash Flow

In the last 12 months, operating cash flow was -25.38 million and capital expenditures -8.44 million, giving a free cash flow of -33.82 million.

Operating Cash Flow	-25.38M
Capital Expenditures	-8.44M
Free Cash Flow	-33.82M
FCF Per Share	n/a

Margins

Gross margin is 73.87%, with operating and profit margins of -27.18% and -41.79%.

Gross Margin	73.87%
Operating Margin	-27.18%
Pretax Margin	-39.87%
Profit Margin	-41.79%
EBITDA Margin	-23.42%
EBIT Margin	-27.18%
FCF Margin	n/a

Dividends & Yields

FRA:SR3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.15%
Shareholder Yield	0.15%
Earnings Yield	-7.43%
FCF Yield	-3.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:SR3 has an Altman Z-Score of 6.87 and a Piotroski F-Score of 1.

Altman Z-Score	6.87
Piotroski F-Score	1